Skip to main content

Month: February 2026

AS Tallink Grupp Investor Webinar introducing the fourth quarter and full-year 2025 results

AS Tallink Grupp will introduce the fourth quarter and full-year 2025 results in an investor webinar. All shareholders and other stakeholders are invited to join the webinar, scheduled to take place on 19 February 2026 at 12:00 (EET). The webinar will be held in English. The financial results will be presented by the Chairman of the Management Board Paavo Nõgene and the members of the Management Board Margus Schults and Harri Hanschmidt. We kindly ask participants to provide their questions before the webinar, no later than 11:00 am on 19 February 2026, by e-mail to: investor@tallink.ee. Due to time constraints, preference will be given to questions submitted in writing before the webinar. How to join the webinar?The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required,...

Continue reading

Clarification regarding media coverage concerning Tatra Defense Systems

CSG (or the “Group”) notes recent media coverage alleging that the involvement of Tatra Defence Systems (“TDS”) in defence contracts represents an artificial intermediary structure intended to divert profits from Tatra Trucks. The Group rejects these allegations. Although the Group has no new material information to disclose, it considers it appropriate to set out the factual position. TDS is an active industrial participant, not a passive intermediary or reseller. TDS, together with its sister company Tatra Defence Vehicle (“TDV”), are both subsidiaries of CSG. They operate a dedicated industrial facility adjacent to the Tatra Trucks production site. These entities employ specialist engineering, integration and production teams. Substantial value-adding activities performed by TDS/TDV include armoured cabin production,...

Continue reading

Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results

Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and preliminary results of 2025. Solid last quarter of 2025 signs-off a record year for Vistin Pharma with all-time high revenue and EBITDA. Revenue in the fourth quarter ended at MNOK 111 compared to MNOK 114 in Q4 2024. Record high sales volume in quarter (+9%), offset by lower global metformin prices compared to same quarter last year. 2025 full year revenue ended at all-time high MNOK 452 compared to MNOK 430 last year. Sales volume increased by 12% in 2025. Fourth quarter EBITDA ended at MNOK 26 compared to MNOK 28 in Q4 2024. EBITDA was positively affected by higher sales volume, offset by product mix compared to same quarter last year. 2025 full year all-time high EBITDA of MNOK 115 compared to MNOK 104 last...

Continue reading

TomTom and AECOM partner to deliver enhanced global infrastructure planning and road traffic management

TomTom and AECOM partner to deliver enhanced global infrastructure planning and road traffic managementTomTom and AECOM partner to deliver enhanced global infrastructure planning and road traffic managementAMSTERDAM, Feb. 12, 2026 (GLOBE NEWSWIRE) — TomTom (TOM2), the specialist in mapping and location technology, today announced a new global partnership with AECOM (NYSE: ACM), the trusted global infrastructure leader. Leveraging TomTom’s historic and real-time traffic measures, AECOM will enhance its mobility and infrastructure planning, transport modelling, and traffic systems management and operations on behalf of both public and private sector clients globally. Through the partnership, AECOM can integrate TomTom’s Traffic Stats, Origin Destination Analysis, Historic Traffic Volumes, Route Monitoring, Live Traffic,...

Continue reading

Press Release: Belén Garijo to become Chief Executive Officer of Sanofi

Belén Garijo to become Chief Executive Officer of Sanofi Paris, February 12, 2026. Sanofi’s Board of Directors met on February 11, 2026, and decided not to renew the Director mandate of Paul Hudson. As a result, Paul Hudson’s last day as Chief Executive Officer will be on February 17, 2026 at the end of business. The Board thanks him for his valuable contributions to the transformation and development of the Group over the last six years. Following the proposal of the Appointments Committee, the Board of Directors appointed Belén Garijo as Chief Executive Officer. She will take up her duties at the end of the Group’s Annual General Meeting on April 29, 2026. The Board will also propose to the shareholder vote the candidacy of Belén Garijo as a director of the Group(*). Olivier Charmeil, Executive Vice President, General Medicines,...

Continue reading

Flow Traders 4Q and FY 2025 Results

Flow Traders 4Q and FY 2025 Results Amsterdam, the Netherlands – Flow Traders Ltd. (Euronext: FLOW) announces its unaudited 4Q and FY 2025 results. HighlightsFlow Traders recorded Net Trading Income of €123.8m and Total Income of €121.0m in 4Q25, a decrease of 20% and 24% when compared to 4Q24, respectively. For full year 2025, Net Trading Income came in at €485.8m and Total Income at €480.5m, increases of 4% and 0% year-on-year, respectively. Flow Traders’ ETP Value Traded increased by 22% in 4Q25 to €516bn in 4Q24. Full year Flow Traders’ ETP Value Traded increased by 26% year-on-year to €1,940b. Fixed Operating Expenses were €52.4m in the quarter, an increase of 17% when compared to 4Q24, due mostly to increased Employee and Technology expenses. Full year, Fixed Operating Expenses totaled €204.1m, an increase of 15% year-on-year. Total...

Continue reading

Publication of the 2025 annual financial results on Thursday, February 26, after market close

Paris, France – February 12, 2026 Full year 2025 financial results and conference call Viridien will publish its full year 2025 results on Thursday, February 26, after market close.The press release and presentation will be made available on www.viridiengroup.com at 5.45 pm (CET) An English-language conference call is scheduled at 6.00 pm (CET) on the same dayParticipants must register for the conference call by clicking here to receive a dial-in number and PIN code. Participants may also join the live webcast by clicking here. A replay of the conference call will also be available, for a period of 12 months, on the Company’s website www.viridiengroup.com. About Viridien: Viridien (www.viridiengroup.com) is an advanced technology, digital and Earth data company that pushes the boundaries of science for a more prosperous and...

Continue reading

UNIBAIL-RODAMCO-WESTFIELD REPORTS FY-2025 EARNINGS

UNIBAIL-RODAMCO-WESTFIELD REPORTS FY-2025 EARNINGS Strong retail performance supported by increased footfall and tenant sales, dynamic leasing activity and record low vacancy c. -355 bps LTV improvement1 thanks to €2.2 Bn of completed or secured disposals and a +1.7% portfolio revaluation2 Successful deliveries including retail opening of Westfield Hamburg-Überseequartier and extension and rebranding of Westfield Černý Most Launch of capital-light growth initiatives through first franchising contract in KSA and acquisition of a 25% stake in St James Quarter, the dominant mall in Edinburgh Successful financing & hedging activity and reduced hybrid cost Good start to ‘A Platform for Growth’ business plan with 2025 AREPS at €9.58 and proposed3 distribution of €4.50/share, up c.+30% vs. FY-2024 2026 AREPS forecasted to be in the range...

Continue reading

Iveco Group 2025 Full Year and Fourth Quarter Results

The following is an extract from the “Iveco Group 2025 Full Year and Fourth Quarter Results” press release (*). The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF: The Board of Directors approves FY 2025 preliminary results. Extraordinary transactions for the sale of Defence and the Tata Motors Tender Offerare on track for completion in line with previously communicated timelines. Consolidated revenues amounted to €13,428 million compared to €14,417 million in 2024. Net revenues of Industrial Activities were €13,129 million compared to €14,064 million in 2024, mainly due to lower volumes in Europe for Truck and Powertrain and an adverse foreign exchange rate impact. Adjusted EBIT was...

Continue reading

Hiab Corporation: Notice to Annual General Meeting 2026

HIAB CORPORATION, STOCK EXCHANGE RELEASE, 12 FEBRUARY 2026 AT 8:25 AM (EET)  Hiab Corporation: Notice to Annual General Meeting 2026 Notice is given to the shareholders of Hiab Corporation to the Annual General Meeting to be held on Tuesday 24 March 2026 at 2:00 p.m. (EET) at Finlandia Hall, Veranda 2, Mannerheimintie 13 e, 00100 Helsinki, Finland. The reception of persons who have registered for the meeting, the distribution of voting tickets and coffee service preceding the meeting will commence at 12:30 p.m. (EET). Shareholders may also exercise their shareholder rights by voting in advance. Instructions for advance voting are provided in section C of this notice. The Annual General Meeting may be followed via a webcast. Instructions for following the webcast are available on the company’s website at www.hiabgroup.com/agm26. It is not...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.